Joshua Stahl

Joshua Stahl is the current CEO at Quantapore. Prior to this, they were the President of Oncology at Invitae from February 2021 to October 2021. Before that, they served as the Chief Scientific Officer Oncology at Invitae from October 2020 to February 2021.

Stahl began their career as a research scientist at Archer Dx from April 2013 to August 2013. Joshua then became the Boulder Site Lead - Senior Research Scientist at Enzymatics from August 2013 to June 2014. After that, they were promoted to Director of NGS R&D/ Assistant Director of Scientific Operations at Enzymatics from June 2014 to January 2015.

In January 2015, Stahl joined ArcherDX, Inc. as Vice President of R&D and Scientific Operations. Joshua was promoted to Chief Scientific Officer and GM in January 2016 and served in that role until January 2019. From January 2019 to January 2020, they served as Chief Scientific Officer and Executive Vice President - Diagnostics at ArcherDX, Inc. In January 2020, they were promoted to Chief Operating Officer and Chief Scientific Officer and served in that role until October 2020.

Stahl has a Bachelor of Arts in Biology from Emory University and a Ph.D. in Genetics from the University of California, Santa Cruz.

Joshua Stahl received a Master of Business Administration (MBA) from the University of Colorado Boulder - Leeds School of Business, a Master of Science (M.Sc.) in Biochemistry from the University of Colorado Boulder, and a Bachelor's degree in Biochemistry and Molecular Biology from West Virginia University.